MedicineCostHelp
COVERAGE ENGINE · PRODUCT + DIAGNOSIS + INSURANCE

How do I get Immgolis Intri
through my insurance?

Immgolis Intri · golimumab-sldi · interchangeable IV biosimilar to Simponi Aria

Coverage first → benefit/formulation → assistance
Immgolis Intri coverage navigator.

FDA approved May 2026 for adult rheumatoid arthritis. Its labeled indication set is narrower than Simponi Aria, so the navigator only presents the indication that applies to this product.

New-product note: FDA approved May 15, 2026. Accord has announced U.S. commercialization; verify current product availability, payer preference and billing code before treatment.

No account, member ID, name, date of birth or email is needed. Your selections stay in this page session.

1
WHY IS THIS MEDICINE BEING GIVEN?

Choose the diagnosis / reason.

Coverage rules can change by diagnosis and sometimes by formulation.

AFTER COVERAGE

Then solve the patient’s out-of-pocket cost.

Financial assistance only helps after the correct product/formulation and benefit path are known.

Accord BioPharma / AccordCares access support →

Important

MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Medical policies, billing codes, product preferences, availability and benefit placement can change. Sources were checked 2026-08-21.

Build a next-step action plan →